Clinical Trial Update: A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing ticagrelor (AZD6140) with clopidogrel in acute coronary syndrome; the study completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• BRILINTA (ticagrelor)
• Plavix (clopidogrel)

Snippet

Sponsor: AstraZeneca | Conditions: Acute Coronary Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2012-03-13